10 Moderna executives
At Moderna, the President, the CFO and the chief scientific, development, safety and people officers are all here, with a CSO for therapeutics research and senior vice presidents over supply chain and over Asia and Emerging Markets; nine hold current roles. The tenth, Juan Andres, held technical operations, quality and strategic partnerships roles until 2023. Partners and suppliers can match a question on manufacturing, safety data or a regional launch to one executive.
Professionals to explore
Andrea Carfi
LinkedInExperience: Chief Scientific Officer · Moderna
$2,693 per 30-minute call
Andrea Carfi, Chief Scientific Officer at Moderna since 2021 (Chief Scientific Officer, Infectious Disease, in Andrea's own description), also held VP and Head of Research, Infectious Disease (2018–2021) and Project Leader and Senior Director, Antigen Design and Selection (2017–2018) there. Earlier, Andrea was Head, Protein Biochemistry and Discovery Project Leader at GSK (2015–2016) and Global Head, Structural Biology at Novartis (2013–2015). The person for infectious disease research and antigen design questions.
Is this you? Claim your profile and get paid for calls.
Craig Kennedy
LinkedInExperience: SVP Supply Chain Management · Moderna
$539 per 30-minute call
SVP Supply Chain Management at Moderna since 2023, Craig Kennedy describes being a Lean and Six Sigma practitioner. At Merck, Craig was Senior Vice President, Global Supply Chain Management (2012–2023), Vice President North America and Consumer Care Operations (2011–2012), Vice President - Plant Manager Stonewall Plant (2008–2011) and Executive Director - SAP Implementation (2006–2008). The supply chain contact for suppliers and contract manufacturers.
Is this you? Claim your profile and get paid for calls.
David Mark Berman
LinkedInExperience: Chief Development Officer · Moderna
$3,365 per 30-minute call
Chief Development Officer at Moderna since 2026, David Mark Berman was Head of Research & Development at Immunocore (2018–2026). Earlier oncology roles were SVP, Head of AZ Immuno-oncology Franchise (2017–2018) and SVP, Head of Oncology at MedImmune (2015–2017) at AstraZeneca, and VP, Head of Immuno-oncology Exploratory Development at Bristol Myers Squibb (2013–2015). Suited to development questions, especially in immuno-oncology.
Is this you? Claim your profile and get paid for calls.
Jamey Mock
LinkedInExperience: Chief Financial Officer · Moderna
$4,039 per 30-minute call
Chief Financial Officer at Moderna since 2022, Jamey Mock was SVP & CFO at PerkinElmer (2018–2022). Earlier GE roles were Vice President, Corporate Audit Staff (2015–2018), Chief Financial Officer, Subsea Systems & Drilling, GE Oil & Gas (2014–2015) and Chief Financial Officer - Engine Services at GE Aerospace (2011–2014). Four CFO titles, at Moderna, PerkinElmer and two GE businesses, make Jamey the pick for company-level finance questions and for comparing how finance works at each.
Is this you? Claim your profile and get paid for calls.
Jose Vega
LinkedInExperience: Chief Safety Officer · Moderna
$3,365 per 30-minute call
Drug safety is Jose Vega's area: Chief Safety Officer at Moderna since 2021 and Chief Safety Officer at Merck (2013–2021), with Amgen roles as Vice President, Global Safety (2008–2013), Vice President, Global Development (2005–2008) and Senior Director, Medical Sciences (2003–2004). Two chief safety officer posts make Jose the call for safety monitoring and safety data questions.
Is this you? Claim your profile and get paid for calls.
Juan Andres
LinkedInExperience: Former President Strategic Partnerships and Enterprise Expansion · Moderna
$3,365 per 30-minute call
Juan Andres was President Strategic Partnerships and Enterprise Expansion at Moderna (2022–2023), Chief Technical Operations and Quality Officer (2018–2022) and Senior VP Manufacturing, Quality and Technical Development (2017–2018). Board seats include Member Board of Directors at Avantor since 2019 and Lonza Board of Directors since 2025. A fit for suppliers and partners asking about Moderna's manufacturing, quality and partnership roles from someone who held them.
Is this you? Claim your profile and get paid for calls.
Lin T. Guey
LinkedInExperience: CSO, Therapeutics Research (TxR) · Moderna
$3,365 per 30-minute call
Lin T. Guey has held CSO, Therapeutics Research (TxR) at Moderna since 2025. Other Moderna CSO titles were CSO, Therapeutics Research Ventures (TXRV) and Biotherapeutics (2023–2025) and CSO, External Research Ventures (XRV) (2022–2023), with Senior Director, Rare Diseases (2016–2019) and Director, Discovery Biology Epidemiology at Shire (2011–2016). The research ventures roles fit questions on external research ventures and on therapeutics and rare disease research.
Is this you? Claim your profile and get paid for calls.
Patrick Bergstedt
LinkedInExperience: Senior Vice President / General Manager – Asia and Emerging Markets · Moderna
$2,019 per 30-minute call
Patrick Bergstedt has been Senior Vice President / General Manager – Asia and Emerging Markets at Moderna since 2020. At Merck: Head Global Marketing and Commercial Operations: Vaccines (2015–2020), President Asia Pacific (2011–2015) and Senior Vice President & General Manager Infectious Diseases & Global Human Health (2001–2011); also Vice President of Sales and Marketing at LifeCell, An Acelity Company (1999–2001). Suited to commercial questions on vaccines in Asia and emerging markets.
Is this you? Claim your profile and get paid for calls.
Stephen Hoge
LinkedInExperience: President · Moderna
$6,731 per 30-minute call
Stephen Hoge has been President of Moderna since 2015, after SVP, Corporate Development, New Drug Concepts, Oncology at Moderna (2012–2014) and Partner at McKinsey & Company (2010–2012). Board Member at Axcella since 2014. With the president role and a prior corporate development and new drug concepts role at the company, Stephen fits questions on how Moderna sets priorities across programs.
Is this you? Claim your profile and get paid for calls.
Tracey Franklin
LinkedInExperience: Chief People and Digital Technology Officer · Moderna
$3,029 per 30-minute call
Tracey Franklin moved from Chief Human Resources Officer at Moderna (2019–2024) to Chief People and Digital Technology Officer in 2024, a title that joins HR and digital technology. Other Merck roles were VP, Chief HR Talent and Strategy Officer (2018–2019), Executive Director, HR Operations (2013–2015) and HR Leader - Compensation and Career Framework & Organizational Readiness (2011–2013). The one to ask about putting people and technology functions under one executive.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Suppliers should start with Craig Kennedy on supply chain or Juan Andres on manufacturing and quality; research partners with Andrea Carfi (infectious disease), Lin T. Guey (therapeutics research) or David Mark Berman (development). Commercial questions about Asia go to Patrick Bergstedt and safety data to Jose Vega, while company-wide priorities, finance and people or digital matters belong with Stephen Hoge, Jamey Mock and Tracey Franklin.
Questions to take into the conversation
- 01What does a supplier need to show Moderna's supply chain team before it becomes a long-term partner?
- 02How does Moderna decide which research programs move into clinical development?
- 03How do Moderna's commercial teams plan a product launch in Asia and emerging markets?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.